Clovis Oncology, Inc.
Pharmaceutical Preparations · 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
官方登记数据
0位关注者
2009成立于
关于 Clovis Oncology, Inc.
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered in Boulder, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline. As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009. In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.
Source: Wikipedia
行业Pharmaceutical Preparations
总部5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
成立2009
法律形式C Corporation
状态营业中
专利41 项专利
IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORSEP4135752A4 · 2024
HIGH DOSAGE STRENGTH TABLETS OF RUCAPARIBCA2955495C · 2023
关键数据
法律信息
| 法定名称 | Clovis Oncology, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1466301在 SEC EDGAR 上查看 ↗ |
| EIN | 90-0475355 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
5500 FLATIRON PARKWAY, SUITE 100, BOULDER, CO 80301
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面